Cargando…
Dietary Lipids and Dyslipidemia in Chronic Kidney Disease
The progression of chronic kidney disease (CKD) leads to altered lipid metabolism. CKD patients exhibit high blood triglyceride (TG) levels, reduced concentrations and functionality of high-density lipoproteins (HDL), and elevated levels of atherogenic small, dense, low-density lipoproteins (sdLDL)....
Autores principales: | Kochan, Zdzislaw, Szupryczynska, Natalia, Malgorzewicz, Sylwia, Karbowska, Joanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472557/ https://www.ncbi.nlm.nih.gov/pubmed/34579015 http://dx.doi.org/10.3390/nu13093138 |
Ejemplares similares
-
Expanded Role of a Dietitian in Monitoring a Gluten-Free Diet in Patients with Celiac Disease: Implications for Clinical Practice
por: Gładyś, Katarzyna, et al.
Publicado: (2021) -
Diet Management of Patients with Chronic Kidney Disease in Bariatric Surgery
por: Potrykus, Marta, et al.
Publicado: (2022) -
Pro-Inflammatory Profile of Adipokines in Obesity Contributes to Pathogenesis, Nutritional Disorders, and Cardiovascular Risk in Chronic Kidney Disease
por: Czaja-Stolc, Sylwia, et al.
Publicado: (2022) -
Multi-omic signatures of atherogenic dyslipidaemia: pre-clinical target identification and validation in humans
por: Olkowicz, Mariola, et al.
Publicado: (2021) -
Dyslipidemia in patients with chronic kidney disease: etiology and management
por: Mikolasevic, Ivana, et al.
Publicado: (2017)